Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07305883
PHASE3

Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain

Sponsor: Tehran University of Medical Sciences

View on ClinicalTrials.gov

Summary

This study aims to compare the analgesic effectiveness and side effects of intranasal ketorolac versus intranasal ketamine for reducing pain prior to digital nerve block procedures in patients with finger injuries in emergency department.

Official title: Intranasal Ketorolac Effectiveness In Comparison To Intranasal Ketamine for Digital Nerve Block Pain; A Randomized, Double Blind Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2025-12-28

Completion Date

2026-08-01

Last Updated

2025-12-26

Healthy Volunteers

No

Interventions

DRUG

Intranasal Ketorolac Tromethamine

30 mg ketorolac will be administered intranasally using mucosal atomizer. Half dose (0.5 cc) in each nostril, Given 5 minutes before digital nerve block.

DRUG

Intranasal ketamine

50 mg ketamine will be administered intranasally using mucosal atomizer,. Half dose (0.5cc) in each nostril, Given 5 minutes before digital nerve block